Resmed Inc Intrinsic Stock Value – ResMed Issues Urgent Safety Notice Regarding Magnetic CPAP Masks

☀️Trending News

RESMED ($NYSE:RMD): ResMed Inc., a leading global medical device company, has issued an urgent safety alert regarding its magnetic CPAP masks. The notice is based on reports of serious skin injuries resulting from the use of such CPAP masks. ResMed is urging consumers to immediately stop using magnetic CPAP masks and contact their healthcare provider for further instructions.

ResMed Inc. is a publicly traded company which designs, manufactures, and markets medical devices and software solutions for diagnosing, treating, and managing sleep-disordered breathing and other respiratory disorders. ResMed is known for its innovative products, such as its Air Solutions product line, which is composed of CPAP (Continuous Positive Airway Pressure) and other non-invasive ventilation devices.

Share Price

The company stated that the masks’ magnetic connection between the forehead support and cushion clip may weaken over time, resulting in an increased risk of the mask separating from the patient’s face while in use. In response to this news, shares of RESMED INC opened at $152.6 on Friday morning and closed at $153.9, representing a 0.8% increase from the previous day’s closing price. The company has advised all users of their magnetic CPAP masks to stop using them immediately and contact RESMED for further instructions. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Resmed Inc. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Resmed Inc. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Resmed Inc. More…

Key Ratios Snapshot

Some of the financial key ratios for Resmed Inc are shown below. More…

Analysis – Resmed Inc Intrinsic Stock Value

At GoodWhale, we have conducted a detailed analysis of RESMED INC‘s financials. Our proprietary Valuation Line has calculated the intrinsic value of RESMED INC share to be approximately $264.6. This means that currently the stock is trading at $153.9 – a price that is undervalued by 41.8%! This presents a great opportunity for investors who wish to benefit from this discrepancy in price. More…

Peers

ResMed’s competitors include Natus Medical Inc, Sanara MedTech Inc, and Avita Corp.

– Natus Medical Inc ($NASDAQ:SMTI)

As of 2022, Sanara MedTech Inc has a market cap of 227.36M and a Return on Equity of -22.91%. The company is a medical device company that develops and manufactures products for the treatment of chronic wounds and other conditions.

– Sanara MedTech Inc ($TPEX:4735)

Avita Corp is a biotechnology company that develops, manufactures, and markets products based on regenerative medicine. The company’s products are used to treat a variety of conditions, including burns, wounds, and skin diseases. Avita’s products are sold in over 30 countries worldwide. The company has a market cap of 1.21B as of 2022 and a return on equity of 9.62%.

Summary

ResMed Inc. is a publicly traded health solutions company with a focus on providing innovative solutions to the sleep-disordered breathing (SDB) market. Over the past year, the company’s stock price has been steadily increasing, making it an attractive investment option for traders. Analysts have cited ResMed’s strong balance sheet, revenue growth, and expansion in emerging markets as reasons for the company’s positive performance. The company also invests heavily in research and development for new products and services.

Additionally, ResMed has recently announced acquisitions and partnerships that are expected to contribute to future growth.